Refine by
Neurovascular Articles & Analysis
49 news found
Carleton Hsia, NanoBlood: NanoBlood LLC has developed VitalHemeTM (nanoRBC), an innovative multifunctional neurovascular protective agent for the prevention and treatment of ischemia, reperfusion injury and damaging inflammatory reactions caused by superoxide generation. ...
” Two types of liquid embolics approved for neurovascular applications are used off label in other parts of the body; Medtronic plc’s Onyx, an ethylene vinyl-alcohol copolymer embolic containing a solvent called dimethyl sulfoxide, and a class of “Super-Glue” products (of the cyanoacrylate family). ...
The third segment is the lower segment, the part from the attachment point of the aerator pili to the base of the hair follicle (neurovascular system). (2) Hair Hair is divided into three types in terms of morphology. ...
” Confluent supports some of the fastest growing medical device markets such as Interventional Neurovascular, Electrophysiology, Structural Heart, and Peripheral Vascular. ...
Rapid Medical, a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER 13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. ...
Today, MicroPort® is focused in covering ten major areas, including Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Endovascular & Peripheral Vascular Diseases, Neurovascular Intervention & Neurosciences, Life Sciences (Endocrine Management), Surgical Devices & ...
ByRobocath
Previously, Haggstrom served as the Global Director of Marketing, Neurovascular at Medtronic, a leading medical equipment manufacturer, where he worked for 18 years. ...
Rapid Medical, a leading developer of advanced neurovascular devices, announces the expansion of its portfolio in the United States and the first Numen™ coil embolization procedure. ...
Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study. ...
“As we continue to advance our robotic-assisted platform, the new facility will support our mission to elevate the standard of care and increase access to cutting-edge treatment for coronary artery and neurovascular disease.” The new facility marks the first of 15 new offices or major facility expansions that Siemens Healthineers plans in the U.S. ...
Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it has launched a new application for its miniscope-based platforms to investigate neuronal activity and blood flow simultaneously, a novel research method that may prove critical to studying neurovascular dynamics in the context of aging, dementia, stroke and other ...
ASGCT Annual Meeting Presentations and Invited Sessions Viral Engineering for the Central Nervous System Engineered AAV Capsids with Exhibit Improved Transduction of the Central Nervous System after CSF Administration Abstract No. 441 Oral Presentation – May 17; 4:00-4:15 pm ET Evaluation of a Human Neurovascular Model to Complement a Parallel Non-Human Primate ...
Its core product portfolio covers several major therapeutic areas including cardio- and neurovascular treatments, respiratory and Ear, Nose & Throat as well as ophthalmic treatments, and selective oncology treatments. ...
Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems and finished devices for medical device OEMs in many of the fastest growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular and ENT. ...
Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced the appointment of Jeffrey Sachs as the Company's Chief Legal & Compliance Officer. ...
Today, MicroPort is focused in covering ten major areas, including cardiovascular intervention & structural heart diseases, electrophysiology & cardiac rhythm management, orthopedics & soft tissue repair, endovascular & peripheral vascular diseases, neurovascular intervention & neurosciences, life sciences (endocrine management), surgical devices & medical ...
ByRobocath
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on November 16, using Robocath’s R-One robot, operated by Dr. ...
ByRobocath
The benefits of this technology can also be applied to the treatment of certain neurovascular diseases. This is largely because precision of movement is a key factor in treating stroke patients; the use of robotics will increase the success rate of these procedures. ...
ByRobocath
This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. Additionally, the trial will gather data on the clinical benefits of the full Zoom Stroke Solution™, the ...
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today the launch of the Armadillo Radial Access System, the latest application of the SelectFlex™ technology and part of the SelectFlex™ Family of Neurovascular access ...